Pseudoangiomatous Stromal Hyperplasia and Breast Cancer Risk
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Pseudoangiomatous stromal hyperplasia (PASH) is a benign localized fibrotic lesion in which clusters of spindle cells form cleftlike spaces, resembling ectatic vessels. Its relationship to breast cancer risk has not been characterized.
Materials and Methods
Histological presence of PASH was evaluated by review of archival slides in a single institution cohort of women who underwent benign excisional breast biopsy from 1967 to 1991. Relative risks for subsequent breast cancer were estimated using standardized incidence ratios (SIR), comparing the observed number of cancers with those expected based on Iowa SEER data (mean follow-up 18.5 years).
PASH was identified in 579 of 9065 biopsies (6.4%). Women with PASH were younger, more likely to have a palpable mass as indication for biopsy, and had less lobular involution compared with those without PASH (all P < 0.001), while they did not differ by family history of breast cancer or degree of epithelial proliferation. Breast cancers occurred in 34 women with PASH (5.9%) and 789 without (8.8%). Women with PASH had lower risk of breast cancer (SIR 1.03, 95% confidence interval [95% CI] 0.71–1.44) than those without PASH (SIR 1.54, 95% CI 1.43–1.65), P = 0.01. Lower levels of breast cancer risk for the PASH group persisted in analyses stratified by age, family history, epithelial proliferation, and involution. The cancers in the PASH group occurred predominantly in the ipsilateral breast more than 5 years after biopsy.
Despite clinical concern generated by palpable density often associated with PASH, this relatively uncommon histological finding does not connote increased risk of subsequent breast cancer.
- Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 1986;17:185–91. CrossRef
- Castro CY, Whitman GJ, Sahin AA. Pseudoangiomatous stromal hyperplasia of the breast. Am J Clin Oncol. 2002;25:213–6. CrossRef
- Singh KA, Lewis MM, Runge RL, Carlson GW. Pseudoangiomatous stromal hyperplasia. A case for bilateral mastectomy in a 12-year-old girl. Breast J. 2007;13:603–6. CrossRef
- Prasad SN, Houserkova D, Svach I, Zlamalova N, Kucerova L, Cwiertka K. Pseudoangiomatous stromal hyperplasia of breast: a case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152:117–20.
- Zubor P, Kajo K, Dussan CA, Szunyogh N, Danko J. Rapidly growing nodular pseudoangiomatous stromal hyperplasia of the breast in an 18-year-old girl. APMIS. 2006;114:389–92. CrossRef
- Wieman SM, Landercasper J, Johnson JM, Ellis RL, Wester SM, Lambert PJ, et al. Tumoral pseudoangiomatous stromal hyperplasia of the breast. Am Surg. 2008;74:1211–4.
- Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008;21:201–7. CrossRef
- Hargaden GC, Yeh ED, Georgian-Smith D, Moore RH, Rafferty EA, Halpern EF, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008;191:359–63. CrossRef
- Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 1995;19:270–7. CrossRef
- Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer. 1989;63:1154–60. CrossRef
- Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. AJR Am J Roentgenol. 1996;166:349–52.
- Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37. CrossRef
- McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009;27:5893–8. CrossRef
- Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–51. CrossRef
- Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006;98:1600–7. CrossRef
- Sng KK, Tan SM, Mancer JF, Tay KH. The contrasting presentation and management of pseudoangiomatous stromal hyperplasia of the breast. Singap Med J. 2008;49:e82–5.
- Choi YJ, Ko EY, Kook S. Diagnosis of pseudoangiomatous stromal hyperplasia of the breast: ultrasonography findings and different biopsy methods. Yonsei Med J. 2008;49:757–64. CrossRef
- Mercado CL, Naidrich SA, Hamele-Bena D, Fineberg SA, Buchbinder SS. Pseudoangiomatous stromal hyperplasia of the breast: sonographic features with histopathologic correlation. Breast J. 2004;10:427–32. CrossRef
- Leon ME, Leon MA, Ahuja J, Garcia FU. Nodular myofibroblastic stromal hyperplasia of the mammary gland as an accurate name for pseudoangiomatous stromal hyperplasia of the mammary gland. Breast J. 2002;8:290–3. CrossRef
- Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol. 2001;25:39–50. CrossRef
- Anderson C, Ricci A, Jr., Pedersen CA, Cartun RW. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol. 1991;15:145–9. CrossRef
- Pruthi S, Reynolds C, Johnson RE, Gisvold JJ. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J. 2001;7:434–9. CrossRef
- Radisky ES, Radisky DC. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord. 2007;8:279–87. CrossRef
- Rozenchan PB, Carraro DM, Brentani H, de Carvalho Mota LD, Bastos EP, e Ferreira EN, Torres CH, et al. Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer. 2009;125:2767–77. CrossRef
- Pseudoangiomatous Stromal Hyperplasia and Breast Cancer Risk
Annals of Surgical Oncology
Volume 17, Issue 12 , pp 3269-3277
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Mayo Clinic, Rochester, MN, USA
- 2. Women’s Cancer Program, Mayo Clinic, Rochester, MN, USA
- 3. Cancer Basic Science, Mayo Clinic, Rochester, MN, USA
- 4. Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
- 5. General Internal Medicine, Mayo Clinic, Rochester, MN, USA
- 6. Medical Oncology, Mayo Clinic, Rochester, MN, USA
- 7. Department of Pathology, University of Michigan, Ann Arbor, MI, USA